The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung CancerMisako Nagasaka, Stephen V. Liu, Vijendra K. Singh et al.|Clinical Lung Cancer|2021Cited by 30
Tumor profiling of gastric and esophageal carcinoma reveal different treatment optionsJohn T. Miura, T. Clark Gamblin, Joanne Xiu et al.|Cancer Biology & Therapy|2015Cited by 19
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)Misako Nagasaka, Asfar S. Azmi, Mohammad Asad et al.|Lung Cancer|2021Cited by 15
Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Jorge J. Nieva, Yasmine Baca et al.|Oncotarget|2021Cited by 12
Health Disparities among Patients with Cancer Who Received Molecular Testing for Biomarker-Directed TherapyElisabeth I. Heath, John L. Marshall, Gregory Dyson et al.|Cancer Research Communications|2024Cited by 6